Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 5
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity.
Vizcarra P, Haemmerle J, Velasco H, Velasco T, Fernández-Escribano M, Vallejo A, Casado JL. Vizcarra P, et al. Among authors: haemmerle j. Vaccine. 2021 Dec 17;39(51):7367-7374. doi: 10.1016/j.vaccine.2021.10.074. Epub 2021 Nov 11. Vaccine. 2021. PMID: 34802792 Free PMC article.
mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection.
Casado JL, Vizcarra P, Martín-Hondarza A, Gómez-Maldonado S, Muedra-Sánchez M, Del Pino J, Mirabella IG, Martín-Colmenarejo S, Haemmerle J, Fernández-Escribano M, Vallejo A. Casado JL, et al. Among authors: haemmerle j. Front Immunol. 2023 Jun 29;14:1127379. doi: 10.3389/fimmu.2023.1127379. eCollection 2023. Front Immunol. 2023. PMID: 37457694 Free PMC article.
Cellular Responses to Membrane and Nucleocapsid Viral Proteins Are Also Boosted After SARS-CoV-2 Spike mRNA Vaccination in Individuals With Either Past Infection or Cross-Reactivity.
Vallejo A, Martín-Hondarza A, Gómez S, Velasco H, Vizcarra P, Haemmerle J, Casado JL. Vallejo A, et al. Among authors: haemmerle j. Front Microbiol. 2022 Feb 11;12:812729. doi: 10.3389/fmicb.2021.812729. eCollection 2021. Front Microbiol. 2022. PMID: 35222312 Free PMC article.
Pre-existing T cell immunity determines the frequency and magnitude of cellular immune response to two doses of mRNA vaccine against SARS-CoV-2.
Casado JL, Vizcarra P, Haemmerle J, Velasco H, Martín-Hondarza A, Rodríguez-Domínguez MJ, Velasco T, Martín S, Romero-Hernández B, Fernández-Escribano M, Vallejo A. Casado JL, et al. Among authors: haemmerle j. Vaccine X. 2022 Aug;11:100165. doi: 10.1016/j.jvacx.2022.100165. Epub 2022 May 2. Vaccine X. 2022. PMID: 35529539 Free PMC article.
T-cell response after first dose of BNT162b2 SARS-CoV-2 vaccine among healthcare workers with previous infection or cross-reactive immunity.
Casado JL, Haemmerle J, Vizcarra P, Rodriguez-Dominguez M, Velasco T, Velasco H, Centenera E, Romero-Hernandez B, Fernandez-Escribano M, Vallejo A. Casado JL, et al. Among authors: haemmerle j. Clin Transl Immunology. 2021 Sep 8;10(9):e1341. doi: 10.1002/cti2.1341. eCollection 2021. Clin Transl Immunology. 2021. PMID: 34522381 Free PMC article.